GFM
NVAX icon

GF Fund Management’s Novavax NVAX Stock Holding History

GF Fund Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5K Sell
3,449
-184
-5% -$1.65K ﹤0.01% 441
2026
Q1 		$29.6K Buy
3,633
+440
+14% +$3.99K ﹤0.01% 456
2025
Q4 		$21.5K Sell
3,193
-301
-9% -$2.27K ﹤0.01% 501
2025
Q3 		$30.3K Sell
3,494
-607
-15% -$4.72K ﹤0.01% 441
2025
Q2 		$25.8K Hold
4,101
– – ﹤0.01% 474
2025
Q1 		$26.3K Buy
4,101
+738
+22% +$6.1K ﹤0.01% 475
2024
Q4 		$27K Buy
+3,363
New +$32.4K ﹤0.01% 444

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

GF Fund Management's NVAX Position: Q2 2026 in Review

GF Fund Management reduced its Novavax (NVAX) stake by 5.1% in Q2 2026, selling an estimated $1.65K and leaving 3,449 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

GF Fund Management first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • GF Fund Management held 3,449 shares of Novavax worth $32.5K as of Q2 2026.
  • GF Fund Management sold 184 Novavax shares in Q2 2026, an estimated $1.65K.
  • Novavax made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #441 holding.
  • GF Fund Management first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.